New oral anticoagulants (NOACs): management of bleeding
Evidence-based neurology checklist on new oral anticoagulants (noacs): management of bleeding: General guidelines There is no need for blood monitoring There is no need for drug dose adjustments There are very few drug or food interactions Control of bleeding Treatment of bleeding NOAC-specific…
General guidelines
- There is no need for blood monitoring
- There is no need for drug dose adjustments
- There are very few drug or food interactions
Control of bleeding
Treatment of bleeding
NOAC-specific management
Related Neurochecklists
References
- Tendera M, Syzdol M, Parma Z. ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation? Cardiol J 2012; 19:4-10.
- Agarwal MB, Verma S, Mahapatra M, et al. Balancing efficacy and bleeding risk in the prevention of stroke due to atrial fibrillation with newer oral anticoagulants. Indian J Hematol Blood Transfus 2012; 28:129-143.
- Christensen H, Cordonnier C, Kõrv J, et al. European Stroke Organisation guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage. Eur Stroke J 2019; 4:294-306.
- Hemphill JC 3rd, Greenberg SM, Anderson CS, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the Management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46:2032-2060.
- Boulouis G, Morotti A, Pasi M, Goldstein JN, Gurol ME, Charidimou A. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis. JNNP 2018; 89:263-270.
- And 1 more. Subscribe to see the full list
